Astrazeneca Plc Earnings

Astrazeneca Plc’s revenue jumped 7.17% since last year same period to $13588Mn in the Q1 2025. On a quarterly growth basis, Astrazeneca Plc has generated -8.75% fall in its revenue since last 3-months.

Astrazeneca Plc’s net profit jumped 33.82% since last year same period to $2916Mn in the Q1 2025. On a quarterly growth basis, Astrazeneca Plc has generated 94.4% jump in its net profits since last 3-months.

Astrazeneca Plc’s net profit margin jumped 24.87% since last year same period to 21.46% in the Q1 2025. On a quarterly growth basis, Astrazeneca Plc has generated 113.04% jump in its net profit margins since last 3-months.

Astrazeneca Plc’s price-to-earnings ratio after this Q1 2025 earnings stands at 27.96.

Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 1.1 - a -1.41% fall from last quarter’s estimates.

Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 1.1.

Astrazeneca Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Astrazeneca Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.